Missing/wrong data?
Log in to edit
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study
scientific article published on 28 February 2012
Author/s
author: François-Clément Bidard, Emmanuelle Charafe-Jauffret, Patrice Viens, Joseph Gligorov, Thomas Bachelot
Work details
Publication date
February 28, 2012
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.